A Palumbo
Overview
Explore the profile of A Palumbo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
237
Citations
4571
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beechinor R, Palumbo A, Chew H, Arora M
ESMO Open
. 2022 Mar;
7(2):100460.
PMID: 35306439
No abstract available.
2.
Beechinor R, Palumbo A, Chew H, Arora M
ESMO Open
. 2022 Feb;
7(1):100393.
PMID: 35131650
No abstract available.
3.
Frantz E, Tjostheim S, Palumbo A, Kellihan H, Stepien R
J Vet Cardiol
. 2021 Jun;
36:89-98.
PMID: 34118563
Introduction: The objective of this retrospective study was to describe the indications, complications, and long-term outcomes in a group of cats that received an epicardial pacing (EP) system. Animals: Twenty...
4.
Demeco A, Marotta N, Moggio L, Pino I, Marinaro C, Barletta M, et al.
J Electromyogr Kinesiol
. 2020 Nov;
56:102485.
PMID: 33186835
Facial nerve paralysis (FNP) has a significant effect on a person's quality of life. In individuals with FNP undergoing facial rehabilitation, methods to analyze the loss of function are useful...
5.
Carpagnano G, Di Lecce V, Quaranta V, Zito A, Buonamico E, Capozza E, et al.
J Endocrinol Invest
. 2020 Aug;
44(4):765-771.
PMID: 32772324
Purpose: Hypovitaminosis D is a highly spread condition correlated with increased risk of respiratory tract infections. Nowadays, the world is in the grip of the Coronavirus disease 19 (COVID 19)...
6.
Castiglia S, Galeoto G, Lauta A, Palumbo A, Tirinelli F, Viselli F, et al.
Funct Neurol
. 2018 Jan;
22(4):221-228.
PMID: 29306359
The Barthel Index (BI) is widely used to determine eligibility criteria for inpatient rehabilitation and to monitor patients' recovery, irrespective of the illnesses that affect them. The culturally adapted Italian...
7.
Bringhen S, DAgostino M, De Paoli L, Montefusco V, Liberati A, Galieni P, et al.
Leukemia
. 2017 Dec;
32(4):979-985.
PMID: 29263440
This multicentre, open-label phase 1/2 trial determined safety and efficacy of weekly carfilzomib plus cyclophosphamide-dexamethasone (wKCyd) in newly diagnosed multiple myeloma (NDMM) patients aged ⩾65 years or transplant ineligible. Patients...
8.
Montevecchi F, Meccariello G, Firinu E, Rashwan M, Arigliani M, De Benedetto M, et al.
Clin Otolaryngol
. 2017 Oct;
43(2):483-488.
PMID: 28981208
Objectives: The aim of this study was to demonstrate in a prospective multicentre study that Barbed Reposition Pharyngoplasty (BRP) procedure is safe and effective in management of obstructive sleep apnoea/hypopnea...
9.
Musto P, Anderson K, Attal M, Richardson P, Badros A, Hou J, et al.
Ann Oncol
. 2017 May;
29(4):1074.
PMID: 28541409
No abstract available.
10.
Dimopoulos M, Stewart A, Masszi T, Spicka I, Oriol A, Hajek R, et al.
Blood Cancer J
. 2017 Apr;
7(4):e554.
PMID: 28430175
Carfilzomib, a proteasome inhibitor, is approved as monotherapy and in combination with dexamethasone or lenalidomide-dexamethasone (Rd) for relapsed or refractory multiple myeloma. The approval of carfilzomib-lenalidomide-dexamethasone (KRd) was based on...